← Back to Search

Artificial Intelligence

Clinical Decision Support System for Depression (AID-ME Trial)

N/A
Waitlist Available
Research Sponsored by Aifred Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

AID-ME Trial Summary

This trial will test a new digital health platform to help doctors treat patients with depression. The goal is to see if it improves patient outcomes.

Eligible Conditions
  • Depression

AID-ME Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effectiveness in Reduction of Depression Symptoms
Rate of Safety - Adverse Events
Secondary outcome measures
Patient Disability with WHODAS rating scale
Response Rate
Time to Remission
Other outcome measures
Medication Adherence Rates
Number of ER visits, admissions, and re-admissions
Patient Questionnaire Response Rate

AID-ME Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Active InterventionExperimental Treatment1 Intervention
Intervention delivered to patients by digital health platform.
Group II: Active ControlActive Control1 Intervention
Intervention delivered to patients by digital health platform.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Clinical Decision Support System
2022
N/A
~200

Find a Location

Who is running the clinical trial?

McDougall ScientificUNKNOWN
McGill UniversityOTHER
394 Previous Clinical Trials
998,287 Total Patients Enrolled
14 Trials studying Depression
2,221 Patients Enrolled for Depression
Aifred HealthLead Sponsor

Media Library

Depression Research Study Groups: Active Intervention, Active Control
Depression Clinical Trial 2023: Digital Health Platform Highlights & Side Effects. Trial Name: NCT04655924 — N/A
Digital Health Platform (Artificial Intelligence) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04655924 — N/A
Depression Patient Testimony for trial: Trial Name: NCT04655924 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many healthcare facilities are currently involved in the implementation of this trial?

"This trial is conducted in Douglas Mental health University Institute (Verdun, Quebec), GMF Centre Médical Métro Monk (Montréal, Ontario), McGill University Health Care Centre (MUHC) in Toronto, Vermont and 16 other medical institutions."

Answered by AI

How many individuals are being observed in this clinical trial?

"Affirmative. The clinicaltrials.gov website reflects that this trial, which was inaugurated on June 16th 2022 is currently recruiting participants. In total, the study requires 500 people from 16 locations to take part in the research."

Answered by AI

Are recruitment efforts for this experiment ongoing?

"Affirmative. Clinicaltrials.gov displays that this research is presently enrolling patients; the trial was first made available on June 16th 2022, and last modified on September 26th 2022. The study requires 500 participants between 16 different sites to complete it"

Answered by AI

Who else is applying?

What state do they live in?
Georgia
Pennsylvania
Connecticut
Other
How old are they?
65+
18 - 65
What site did they apply to?
Temple University
Yale University, VA Connecticut Healthcare System
VA New Haven, VA Connecticut Healthcare System
Other
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
1
3+

Why did patients apply to this trial?

Anything that improves my mental health and well being is worth a try. I've finally decided to love forward in addressing my medical condition of depression. I was against using the pharmaceutical drugs but now am a bit open to us now to solve my depression.
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
Artificial Intelligence in Depression - Medication Enhancement
Aifred Health 2022. "Artificial Intelligence in Depression - Medication Enhancement". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04655924.
~33 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top